CD8A and neoplasm: Furthermore, CD8+ T cell‐specific depletion in CT26 tumor‐bearing mice markedly reduced the anti‐tumor efficacy of the dual‐drug combination therapy, suggesting a mechanistic dependence on CD8+ T cell‐mediated immune activation (Figure S8A–D, Supporting Information).